 Cross-Over Studies
"Cross-Over Studies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed)
| Descriptor ID |
D018592
|
| MeSH Number(s) |
E05.318.780.150 N05.715.360.780.150 N06.850.520.445.150
|
| Concept/Terms |
Cross-Over Studies- Cross-Over Studies
- Cross Over Studies
- Cross-Over Study
- Studies, Cross-Over
- Study, Cross-Over
- Crossover Studies
- Crossover Study
- Studies, Crossover
- Study, Crossover
- Cross-Over Trials
- Cross Over Trials
- Trial, Cross-Over
- Trials, Cross-Over
- Crossover Trials
- Trial, Crossover
- Trials, Crossover
Cross-Over Design- Cross-Over Design
- Cross Over Design
- Cross-Over Designs
- Design, Cross-Over
- Designs, Cross-Over
- Crossover Design
- Crossover Designs
- Design, Crossover
- Designs, Crossover
|
Below are MeSH descriptors whose meaning is more general than "Cross-Over Studies".
Below are MeSH descriptors whose meaning is more specific than "Cross-Over Studies".
This graph shows the total number of publications written about "Cross-Over Studies" by people in this website by year, and whether "Cross-Over Studies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 | | 1994 | 0 | 2 | 2 | | 1995 | 0 | 6 | 6 | | 1996 | 0 | 14 | 14 | | 1997 | 0 | 9 | 9 | | 1998 | 0 | 4 | 4 | | 1999 | 0 | 8 | 8 | | 2000 | 0 | 10 | 10 | | 2001 | 0 | 6 | 6 | | 2002 | 0 | 13 | 13 | | 2003 | 0 | 7 | 7 | | 2004 | 0 | 14 | 14 | | 2005 | 0 | 6 | 6 | | 2006 | 0 | 6 | 6 | | 2007 | 0 | 9 | 9 | | 2008 | 0 | 12 | 12 | | 2009 | 0 | 13 | 13 | | 2010 | 1 | 12 | 13 | | 2011 | 0 | 9 | 9 | | 2012 | 0 | 16 | 16 | | 2013 | 0 | 12 | 12 | | 2014 | 0 | 8 | 8 | | 2015 | 0 | 7 | 7 | | 2016 | 0 | 13 | 13 | | 2017 | 0 | 6 | 6 | | 2018 | 0 | 10 | 10 | | 2019 | 0 | 15 | 15 | | 2020 | 0 | 6 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Cross-Over Studies" by people in Profiles.
-
Fox AP, Wagner KR, Towle VL, Xie KG, Xie Z. Caffeine reverses the unconsciousness produced by light anesthesia in the continued presence of isoflurane in rats. PLoS One. 2020; 15(11):e0241818.
-
Garcia-Manero G, Griffiths EA, Steensma DP, Roboz GJ, Wells R, McCloskey J, Odenike O, DeZern AE, Yee K, Busque L, O'Connell C, Michaelis LC, Brandwein J, Kantarjian H, Oganesian A, Azab M, Savona MR. Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study. Blood. 2020 08 06; 136(6):674-683.
-
Sternlicht HK, Bakris GL. Reductions in albuminuria with SGLT2 inhibitors: a marker for improved renal outcomes in patients without diabetes? Lancet Diabetes Endocrinol. 2020 07; 8(7):553-555.
-
Benavides R, Vsevolozhskaya O, Cattaneo S, Zaykin D, Brenton A, Parisien M, Verma V, Khoury S, Gilron I, Diatchenko L. A functional polymorphism in the ATP-Binding Cassette B1 transporter predicts pharmacologic response to combination of nortriptyline and morphine in neuropathic pain patients. Pain. 2020 03; 161(3):619-629.
-
Farrell CM, McNeilly AD, Fournier P, Jones T, Hapca SM, West D, McCrimmon RJ. A randomised controlled study of high intensity exercise as a dishabituating stimulus to improve hypoglycaemia awareness in people with type 1 diabetes: a proof-of-concept study. Diabetologia. 2020 04; 63(4):853-863.
-
Wolbrink TA, van Schaik SM, Turner DA, Staffa SJ, Keller E, Boyer DL, Chong G, Cross J, Del Castillo S, Feng A, Hum RS, Jacob James E, Johnson A, Kandil S, Kneyber M, Rameshkumar R, Levin A, Lodha R, Jayashree M, Olivero A, Oberender F, Panesar RS, Pooni PA, Rehder KJ, Sankaranarayanan S, Scheffler M, Sharara-Chami R, Siems AL, Padur Sivaraman R, Tegtmeyer K, Valentine S, Villois F, von Saint Andre-von Arnim A, Winkler M, Dede C, Burns JP. Online Learning and Residents' Acquisition of Mechanical Ventilation Knowledge: Sequencing Matters. Crit Care Med. 2020 01; 48(1):e1-e8.
-
Luke JJ, Ascierto PA, Carlino MS, Gershenwald JE, Grob JJ, Hauschild A, Kirkwood JM, Long GV, Mohr P, Robert C, Ross M, Scolyer RA, Yoon CH, Poklepovic A, Rutkowski P, Anderson JR, Ahsan S, Ibrahim N, M Eggermont AM. KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma. Future Oncol. 2020 Jan; 16(3):4429-4438.
-
Reich K, Griffiths CEM, Gordon KB, Papp KA, Song M, Randazzo B, Li S, Shen YK, Han C, Kimball AB, Armstrong AW, Foley P, Blauvelt A. Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials. J Am Acad Dermatol. 2020 Apr; 82(4):936-945.
-
Limberg JK, Johnson BD, Mozer MT, Holbein WW, Curry TB, Prabhakar NR, Joyner MJ. Role of the carotid chemoreceptors in insulin-mediated sympathoexcitation in humans. Am J Physiol Regul Integr Comp Physiol. 2020 01 01; 318(1):R173-R181.
-
Hanlon EC. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide). Psychoneuroendocrinology. 2020 01; 111:104471.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|